Qool Therapeutics is a biotech startup founded in 2005 that is dedicated to creating non-invasive, efficient temperature management therapies. Their mission is to preserve cells, improve patient quality of life, and extend life. The last recorded investment for the company was a significant $8.00M Series A round, which took place on 28 November 2017.
The investors participating in this round included Western Technology Investment, BioPacific Ventures, Zhongji Holdings Groups, BrilliMedical International Corporation, and TAMCAP. Qool Therapeutics operates in the biotechnology, healthcare, and pharmaceutical sectors.
